Antibiotic Selection for GBS-Positive Pregnant Women with Penicillin Allergy and Hives
For a pregnant woman who is GBS-positive with a penicillin allergy manifesting as hives (urticaria), you should administer vancomycin 1 g IV every 12 hours until delivery if susceptibility testing is unavailable, or clindamycin 900 mg IV every 8 hours until delivery if the GBS isolate is susceptible to both clindamycin and erythromycin. 1
Risk Stratification for Penicillin Allergy
Hives (urticaria) following penicillin administration classify this patient as high-risk for anaphylaxis. 1 According to CDC guidelines, patients with a history of anaphylaxis, angioedema, respiratory distress, or urticaria following penicillin or cephalosporin administration are considered high-risk and should NOT receive penicillin, ampicillin, or cefazolin for GBS prophylaxis. 1
This is a critical distinction because:
- Low-risk penicillin allergies (isolated rash, itching, or nausea without urticaria) can safely receive cefazolin 2 g IV initial dose, then 1 g IV every 8 hours until delivery 1
- High-risk allergies (including hives/urticaria) require alternative non-β-lactam antibiotics 1
Antibiotic Selection Algorithm for High-Risk Allergy
Step 1: Check GBS Susceptibility Testing
If clindamycin and erythromycin susceptibility testing was performed on the prenatal GBS isolate: 1
GBS susceptible to BOTH clindamycin AND erythromycin: Use clindamycin 900 mg IV every 8 hours until delivery 1
GBS susceptible to clindamycin but RESISTANT to erythromycin: Only use clindamycin if testing for inducible clindamycin resistance (D-zone test) is negative; otherwise use vancomycin 1
GBS resistant to clindamycin OR demonstrates inducible clindamycin resistance: Use vancomycin 1 g IV every 12 hours until delivery 1
Step 2: If Susceptibility Testing Not Available
Use vancomycin 1 g IV every 12 hours until delivery as the default agent. 1 This is the preferred agent when susceptibility results are unknown at the time of labor. 1
Critical Pitfalls to Avoid
Do not use cefazolin in this patient. Despite cefazolin being an excellent alternative for low-risk penicillin allergies, urticaria/hives represent an IgE-mediated reaction that places the patient at high risk for cross-reactivity with cephalosporins. 1 The CDC explicitly states that patients with urticaria following penicillin should not receive cefazolin. 1
Erythromycin is no longer acceptable for GBS prophylaxis in penicillin-allergic patients at high risk for anaphylaxis. 1 This represents a change from older guidelines.
Ensure susceptibility testing is ordered. Clinicians must inform laboratories of the need for clindamycin and erythromycin susceptibility testing when GBS screening is performed on penicillin-allergic women at high risk for anaphylaxis. 1 This testing should ideally be performed during the routine 36-37 week GBS screening (updated from the previous 35-37 week window). 2
Timing Considerations
Administer antibiotics at least 4 hours before delivery for optimal efficacy. 1 Both vancomycin and clindamycin achieve adequate intraamniotic concentrations when given for at least 4 hours before delivery, though their pharmacokinetics differ from penicillin. 1
Clinical Context and Evidence Quality
The evidence supporting these recommendations comes from high-quality CDC guidelines published in 2010 and endorsed by the American Academy of Pediatrics in 2011. 1 These guidelines were updated in 2019-2020 with minor modifications to screening timing but maintained the same antibiotic selection algorithm for penicillin-allergic patients. 2
Recent observational data confirm that pregnant patients with documented penicillin allergies frequently receive alternative antibiotics (73.7% in one study), and this practice is associated with increased neonatal monitoring but not necessarily worse outcomes when guidelines are followed appropriately. 3, 4 However, the use of non-β-lactam antibiotics when not truly necessary can lead to increased antibiotic resistance and costs. 5, 6
Consider penicillin allergy testing or delabeling in future pregnancies. Recent evidence suggests that penicillin skin testing and allergy verification can safely identify patients who can receive β-lactam antibiotics, providing both short- and long-term health benefits. 2, 7 One study found that cefazolin was safely administered to 97.8% of pregnant patients with documented penicillin allergies, though this should not change acute management for patients with documented urticaria. 7